Results 131 to 140 of about 962 (189)

Cost elements to be considered in estimates for microcosting studies in peritoneal dialysis (PD) therapy in Latin America. [PDF]

open access: yesJ Bras Nefrol
Moraes-Júnior CS   +23 more
europepmc   +1 more source

[Most frequently used drugs in suicide attempts and their organic complications in a tertiary care hospital]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Saucedo-Montero HA   +5 more
europepmc   +1 more source

CD74 en la enfermedad renal

open access: yes
La enfermedad renal es una condición clínica heterogénea que afecta la funcionalidad de los riñones y se caracteriza por su naturaleza silenciosa. El fracaso renal agudo (FRA) es característico del paciente hospitalizado y tiene una alta mortalidad (50%), lo que supone 2 millones de muertes al año.
openaire   +1 more source

[Effectiveness of GLP-1 receptor agonists in managing patients with type 2 diabetes]. [PDF]

open access: yesAten Primaria
Bejarano Romero F   +5 more
europepmc   +1 more source

Social capital and its association with clinically significant depressive symptoms in patients with end-stage kidney disease in Mexico. [PDF]

open access: yesBMC Public Health
Alanis-Ocádiz A   +7 more
europepmc   +1 more source

Barriers and Facilitators to Adherence to a Healthy Diet Across the Spectrum of Chronic Kidney Disease. [PDF]

open access: yesPatient Prefer Adherence
Trigueros-Flores XB   +10 more
europepmc   +1 more source

Cohort profile: the CORDELIA study (Collaborative cOhorts Reassembled Data to study mEchanisms and Longterm Incidence of chronic diseAses). [PDF]

open access: yesEur J Epidemiol
Hernáez Á   +86 more
europepmc   +1 more source

Cap. 16. Enfermedad renal crónica

open access: yesNefrología, 2010
openaire   +1 more source

Effectiveness and Safety of Antibiotics in Kidney Transplant Recipients With Asymptomatic Bacteriuria: A Systematic Review and Meta-analysis of Randomized Controlled Trials. [PDF]

open access: yesOpen Forum Infect Dis
Aslan AT   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy